Physician profile
Brandi Renee Trujillo
NPI 1467824433
$3,223.34
in general payments reported to CMS, 2019-2025
30 companies · $1,497 in 2025
The $1,497 reported for 2025 was more than what 96% of Critical Care Medicine (Nurse Practitioner) providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.72 · 2023: $602 · 2024: $1,075 · 2025: $1,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,173.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $536.02 | 2023-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $508.65 | 2023-2025 | Airsupra, Fasenra, Breztri |
| Genzyme Corporation | $265.13 | 2024-2025 | |
| Insmed, INC. | $261.83 | 2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $219.27 | 2024-2025 | Dupixent |
| Baxter Healthcare | $156.41 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $114.29 | 2023-2025 | Tezspire |
| Mylan Specialty L.P. | $106.72 | 2023-2024 | Yupelri, Tobi Podhaler |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.14 | 2024-2025 | Ofev |
| Merck Sharp & Dohme LLC | $85.46 | 2023-2025 | Keytruda, Zerbaxa, Dificid |
| Novartis Pharmaceuticals Corporation | $80.26 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $75.52 | 2023-2024 | Opsumit, Uptravi |
| United Therapeutics Corporation | $75.38 | 2024 | Tyvaso |
| Verona Pharma, INC. | $66.46 | 2025 | Ohtuvayre |
| Ani Pharmaceuticals, INC. | $64.12 | 2024-2025 | Purified Cortrophin Gel |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $58.58 | 2024-2025 | Fetroja |
| Viatris Specialty LLC | $58.24 | 2025 | Yupelri |
| Grifols USA, LLC | $55.10 | 2023-2025 | Prolastin-C Liquid |
| Philips North America LLC | $40.42 | 2024-2025 | Home Pi Undivided, (Ee0) Cc Others Undivided |
| Takeda Pharmaceuticals U.S.A., INC. | $37.15 | 2023-2025 | Glassia |
| Tactile Systems Technology INC | $36.27 | 2023 | Flexitouch Plus, Entre Plus |
| Potrero Medical, INC. | $33.19 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $27.18 | 2023-2024 | Vibativ |
| Alexion Pharmaceuticals, INC. | $26.92 | 2025 | Ultomiris |
| Atricure, INC. | $25.91 | 2023 | |
| Jazz Pharmaceuticals INC. | $23.48 | 2025 | |
| Electromed, INC. | $21.00 | 2025 | Smartvest |
| Pharming Healthcare, INC. | $19.91 | 2024 | Ruconest |
| Inogen, INC. | $19.88 | 2024 | |
| Pfizer INC. | $19.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandi Trujillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.